Merck MRK
NYSE MRK
$146.77 -0.36 (-0.24%)
At close: Sep 18, 2026 · 4:00 PM EDT

Merck (MRK) Other Working Capital Changes (2009 - 2026)

Merck's (MRK) quarterly Other Working Capital Changes came in at -$222.0 million in Q1 2011, down 237.89% year-over-year from $161.0 million in Q1 2010, and down 233.33% quarter-over-quarter from -$66.6 million in Q4 2010.

Analysis

Merck (MRK) Other Working Capital Changes (2009 - 2026) Analysis & Trends

Merck (MRK) has reported Other Working Capital Changes for 3 consecutive years, with -$222.0 million the latest figure, recorded in Q1 2011.

  • On a quarterly basis, Other Working Capital Changes fell 237.89% year-over-year to -$222.0 million in Q1 2011; TTM through Mar 2011 was -$6.0 million, a 98.71% increase from a year earlier, with the FY2010 full-year figure at $377.0 million, up 170.47% from the prior year.
  • Other Working Capital Changes was -$222.0 million for Q1 2011 at Merck, down from -$66.6 million in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $3.7 billion in Q1 2025 and troughed at -$2.6 billion in Q3 2024.
  • A 5-year average of $538.9 million and a median of $488.5 million in 2023 frame the typical range for Other Working Capital Changes.
  • The widest YoY moves for Other Working Capital Changes: up 185.85% in 2010, down 1700.0% in 2010.
  • Over 3 years, Other Working Capital Changes stood at -$3.7 million in 2009, then slumped by 1700.0% to -$66.6 million in 2010, then slumped by 233.33% to -$222.0 million in 2011.
  • The last three Other Working Capital Changes figures came in at -$222.0 million (Q1 2011), -$66.6 million (Q4 2010), and $6.6 million (Q3 2010), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -423.00 Mn
Jun 30, 2026 -423.00 Mn
Mar 31, 2026 1.61 Bn
Mar 31, 2026 1.61 Bn
Dec 31, 2025 -1.35 Bn
Dec 31, 2025 -1.35 Bn
Sep 30, 2025 -1.31 Bn
Sep 30, 2025 -1.31 Bn
Jun 30, 2025 2.26 Bn
Jun 30, 2025 2.26 Bn
Mar 31, 2025 3.71 Bn
Mar 31, 2025 3.71 Bn
Dec 31, 2024 -396.00 Mn
Dec 31, 2024 -396.00 Mn
Sep 30, 2024 -2.58 Bn
Sep 30, 2024 -2.58 Bn
Jun 30, 2024 1.01 Bn
Jun 30, 2024 1.01 Bn
Mar 31, 2024 3.38 Bn
Mar 31, 2024 3.38 Bn